Minor serous or clear-cell components in early-stage endometrioid adenocarcinoma: is it ever insignificant?

References

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J. Clin.59(4), 225–249 (2009).
   PubMed Web of Science ®Google Scholar
• Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer2, 37 (2002).
   PubMed Web of Science ®Google Scholar
• Creasman WT, Odicino F, Maisonneuve P et al. Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet.95(Suppl. 1), S105–S143 (2006).
   PubMed Web of Science ®Google Scholar
• Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol.15, 10–17 (1983).
   PubMed Web of Science ®Google Scholar
• Lax SF, Kurman RJ. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Verh. Dtsch. Ges. Pathol.81, 228–232 (1997).
   PubMedGoogle Scholar
• Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J. Clin. Oncol.24(29), 4783–4791 (2006).
   PubMed Web of Science ®Google Scholar
• Fadare O, Zheng W. Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of type II endometrial cancers. Diagn. Pathol.3, 6 (2008).
   PubMed Web of Science ®Google Scholar
• Fadare O, Zheng W. Insights into endometrial serous carcinogenesis and progression. Int. J. Clin. Exp. Pathol.2(5), 411–432 (2009).
   PubMed Web of Science ®Google Scholar
• Fadare O, Liang SX, Ulukus EC, Chambers SK, Zheng W. Precursors of endometrial clear cell carcinoma. Am. J. Surg. Pathol.30(12), 1519–1530 (2006).
   PubMed Web of Science ®Google Scholar
• Slomovitz BM, Burke TW, Eifel PJ et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol. Oncol.91, 463–469 (2003).
   PubMed Web of Science ®Google Scholar
• Chan JK, Loizzi V, Youssef M et al. Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol. Oncol.90, 181–185 (2003).
   PubMed Web of Science ®Google Scholar
• Gehrig PA, Groben PA, Fowler WC Jr, Walton LA, Van Le L. Noninvasive papillary serous carcinoma of the endometrium. Obstet. Gynecol.97, 153–157 (2001).
   PubMed Web of Science ®Google Scholar
• Fader AN, Boruta D, Olawaiye AB, Gehrig PA. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Curr. Opin. Obstet. Gynecol.22(1), 21–29 (2010).
   PubMed Web of Science ®Google Scholar
• Carcangiu ML, Chambers JT. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. Int. J. Gynecol. Pathol.14(1), 30–38 (1995).
   PubMed Web of Science ®Google Scholar
• Carcangiu ML, Chambers JT. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol. Oncol.47(3), 298–305 (1992).
   PubMed Web of Science ®Google Scholar
• Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am. J. Surg. Pathol.16(6), 600–610 (1992).
   PubMed Web of Science ®Google Scholar
• Boruta DM 2nd, Gehrig PA, Groben PA et al. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference? Cancer101(10), 2214–2221 (2004).
   PubMed Web of Science ®Google Scholar
• Lim P, Al Kushi A, Gilks B, Wong F, Aquino-Parsons C. Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome. Cancer91(4), 752–757 (2001).
   PubMed Web of Science ®Google Scholar
• Williams KE, Waters ED, Woolas RP, Hammond IG, McCartney AJ. Mixed serous–endometrioid carcinoma of the uterus: pathologic and cytopathologic analysis of a high-risk endometrial carcinoma. Int. J. Gynecol. Cancer.4(1), 7–18 (1994).
   PubMed Web of Science ®Google Scholar
• Halperin R, Zehavi S, Langer R, Hadas E, Bukovsky I, Schneider D. Uterine papillary serous carcinoma (pure and mixed type) compared with moderately and poorly differentiated endometrioid carcinoma. A clinicopathologic study. Eur. J. Gynaecol. Oncol.23(4), 300–304 (2002).
   PubMed Web of Science ®Google Scholar
• Quddus MR, Sung CJ, Zhang C, Lawrence WD. Minor serous and clear cell components adversely affect prognosis in ‘mixed-type’ endometrial carcinomas: a clinicopathologic study of 36 stage-I cases. Reprod. Sci.17(7), 673–678 (2010).
   PubMed Web of Science ®Google Scholar
• Malpica A, Tornos C, Burke TW, Silva EG. Low-stage clear-cell carcinoma of the endometrium. Am. J. Surg. Pathol.19, 769–774 (1995).
   PubMed Web of Science ®Google Scholar
• Clement PB, Young RH. Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv. Anat. Pathol.11(3), 117–142 (2004).
   PubMed Web of Science ®Google Scholar
• Soslow RA, Pirog E, Isacson C. Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis. Am. J. Surg. Pathol.24, 726–732 (2000).
   PubMed Web of Science ®Google Scholar